|
|
Countries covered: United States
Approximately eight million surgical procedures are performed annually in the U.S. to treat tissue damage resulting from accidents, birth defects, hereditary disorders, and other diseases. Because traditional tissue repair procedures are inefficient, potentially painful to the patient, and costly to perform, healthcare providers are increasingly interested in finding alternative methods of treatment. The emerging field of tissue engineering is dedicated to developing a range of new solutions, from traditional synthetic substitutes and nonliving processed tissue to innovatiove injectable growth factors, to overcome the challenges of tissue repair. This Frost & Sullivan study evaluates the markets for skin, cartilage, and bone tissue engineering solutions. By pinpointing market drivers and restraints, and tracking industry trends, this research offers its users a valuable tool in preparing for this fast-growing field. Minimizing Costs Key to Market Penetration The successful adoption of many products depends largely on their clinical efficiency. "At present, tissue repair treatments present a major economic burden to the U.S. healthcare structure," according to the study's author. New tissue engineered products are being developed to reduce these costs by providing a much more clinically efficient option which employs the patient's own body repair mechanisms rather then outside intervention. Some participants are already developing tissue engineering methods that will help contain costs. "One such platform technology is the injection of growth factors, which promises to reduce surgery time and incident of disease," says the analyst. This study monitors pricing shifts and assesses their impact, enabling your firm to ultimately achieve better market penetration. Education Must Remain an Essential Component for Widespread Adoption "Continuing medical education is an excellent way to introduce new products to the healthcare community, which is largely unaware of emerging technologies," says the author. For tissue engineering solutions, decision makers tend to be surgeons specializing in burns, diabetes, and orthopedics. Because this is a relatively new field with little clinical data available, providing physician education will be crucial in the marketing of specific products and procedures. This research surveys the competitive field and identifies winning strategies, enabling your company to capitalize on a promising industry. |
Additional Information
Market Participants
Advanced Tissue Sciences, Inc.
AlloSource
American Home Products Corp.
CO.don
Collagenesis, Inc.
Cook Biopharma
CrossCart, Inc.
Cryolife, Inc.
Curis, Inc.
DePuy/Johnson & Johnson
GenSci Regeneration Sciences, Inc.
Genzyme BioSurgery/Genzyme Corp.
Integra LifeSciences Holdings Corp.
Interpore Cross International
Johnson & Johnson/Ethicon, Inc.
LifeCell Corp.
Medtronic Sofamor Danek
Musculoskeletal Transplant Foundation
Novartis AG
Organogenesis, Inc.
Orquest, Inc.
ORTEC International, Inc.
OrthoLogic
Orthovita, Inc.
Osiris Therapeutics, Inc.
OsteoBiologics, Inc.
Osteotech, Inc.
Regeneration Technologies, Inc.
Smith & Nephew
Sulzer Orthopedics, Inc.
Tissue Engineering, Inc.
Wright Medical Technology, Inc.
Zimmer, Inc.
More United States Tissue Engineering Reports
U.S. Tissue Engineering Markets by
Frost & Sullivan
The scope of this research service primarily includes tissue engineering products and companies in the wound care and surgery space. Surgery includes cardiovascular, orthopedics, neurology, ...
U.S. Market for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering Products 2012 by
iData Research, Inc.
The total U.S. market for dental bone graft substitutes and other biomaterials is expected to grow at a CAGR of 12% over the 2012-2018 forecast ...
Stem Cell - Analysis and Market Forecasts, 2006-2016 by
RRY Publications
Sales of stem cell products in the United States reached $16.4 million in 2006 and are expected to surpass $35 million in 2007, according to ...
The Market for Organ and Tissue Transplantation and Alternatives by
BCC Research
Organ failure and tissue loss account for half the medical spending in the U.S. In theory, transplantation is the last therapeutic option available to people ...
Opportunities in Stem Cell Technology by
Kalorama Information
In the nascent, but rapidly growing field of stem cell therapies, products are a long way from being commercialized. However, the market potential for stem ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>